CNBX Pharmaceuticals Revenue

In the fiscal year ending August 31, 2024, CNBX Pharmaceuticals had annual revenue of $130.07K, down -68.29%.

Revenue

130.07K

Revenue Growth

-68.29%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

16.79K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2024	130.07K	-280.09K	-68.29%
Aug 31, 2023	410.17K	380.21K	1,269.13%
Aug 31, 2022	29.96K	-	-
Aug 31, 2021	-	-	-
Aug 31, 2020	7.16K	-2.69K	-27.29%
Aug 31, 2019	Pro	Pro	Pro
Aug 31, 2018	Pro	Pro	Pro
Aug 31, 2017	Pro	Pro	Pro
Aug 31, 2016	Pro	Pro	Pro
Aug 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SS Innovations International	20.65M
Endo Inc.	1.76B
Veradigm	588.02M
Elite Pharmaceuticals	70.00M
Northwest Biotherapeutics	1.38M
Glass House Brands	200.90M
BioStem Technologies	301.83M
American Oncology Network	1.76B

Revenue Rankings

CNBX Pharmaceuticals News

2 years ago - Cannabis REITs: Smoked Out - Seeking Alpha
2 years ago - CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma - PRNewsWire
2 years ago - CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy - PRNewsWire
2 years ago - CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel - PRNewsWire
2 years ago - CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate - PRNewsWire
2 years ago - CNBX Pharmaceuticals Announces New Patent Granted in Australia - PRNewsWire
3 years ago - CNBX Pharmaceuticals Granted Patent in Hong Kong - PRNewsWire
3 years ago - Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals - PRNewsWire

More News